PHARMAESSENTIA Trademark

Trademark Overview

On Monday, October 20, 2025, a trademark application was filed for PHARMAESSENTIA with the United States Patent and Trademark Office. The USPTO has given the PHARMAESSENTIA trademark a serial number of 99452895. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, March 6, 2026. This trademark is owned by PHARMAESSENTIA CORPORATION. The PHARMAESSENTIA trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and health supplements; pharmaceutical preparations for treating oncological and/or autoimmune diseases; pharmaceutical preparations for cancer, for example, treating myeloproliferative neoplasms (MPNs); pharmaceutical preparations for treating polycythemia vera (PV); pharmaceutical preparations for treating essential thrombocythemia (ET); pharmaceutical preparations for treating myelofibrosis (MF); pharmaceutical preparations for treating chronic myelogenous leukemia (CML); pharmaceutical preparations for treating chronic neutrophilic leukemia (CNL). Injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for oncological treatment, in particular, MPNs
pharmaessentia

General Information

Serial Number99452895
Word MarkPHARMAESSENTIA
Filing DateMonday, October 20, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, March 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of A black square with two sharp white mountain peaks with feathering at the bottom of one side of each mountain; the word PHARMAESSENTIA in black beside the black square.
Goods and ServicesDietary and health supplements; pharmaceutical preparations for treating oncological and/or autoimmune diseases; pharmaceutical preparations for cancer, for example, treating myeloproliferative neoplasms (MPNs); pharmaceutical preparations for treating polycythemia vera (PV); pharmaceutical preparations for treating essential thrombocythemia (ET); pharmaceutical preparations for treating myelofibrosis (MF); pharmaceutical preparations for treating chronic myelogenous leukemia (CML); pharmaceutical preparations for treating chronic neutrophilic leukemia (CNL). Injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for oncological treatment, in particular, MPNs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePHARMAESSENTIA CORPORATION
Party Type10 - Original Applicant
Legal Entity Type22 - NOT AVAILABLE
AddressTaipei City 115 115603
TW

Trademark Events

Event DateEvent Description
Monday, October 20, 2025NEW APPLICATION ENTERED
Monday, October 20, 2025APPLICATION FILING RECEIPT MAILED
Thursday, March 5, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 6, 2026ASSIGNED TO EXAMINER

Related Keywords

pharmaessentia pharmaceutical preparations treating oncological diseases autoimmune containing injector leukemia chronic